Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$65.8M |
| 2 |
Las Vegas Sands
LVS
|
+$61.9M |
| 3 |
Consolidated Edison
ED
|
+$42.4M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$39.1M |
| 5 |
CMS Energy
CMS
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$68.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$41.1M |
| 3 |
Pinnacle West Capital
PNW
|
+$25.6M |
| 4 |
Eversource Energy
ES
|
+$23.6M |
| 5 |
FirstEnergy
FE
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 15.61% |
| 2 | Technology | 12.98% |
| 3 | Industrials | 12.91% |
| 4 | Consumer Discretionary | 9.54% |
| 5 | Financials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Darden Restaurants
DRI
$25.6B
| $319K | 0.01% |
+2,700
| New | +$329K |
|
|
CEO
852
DELISTED
CNOOC Limited
CEO
| $319K | 0.01% |
+2,096
| New | +$330K |
|
|
KEM
853
DELISTED
KEMET Corporation
KEM
| $318K | 0.01% |
+17,500
| New | +$330K |
|
|
PDCE
854
DELISTED
PDC Energy, Inc.
PDCE
| $316K | 0.01% |
+11,400
| New | +$342K |
|
855
Smith & Wesson
SWBI
$612M
| $314K | 0.01% |
69,864
+702
| +1% | +$4.23K |
|
856
Corcept Therapeutics
CORT
$13.3B
| $312K | 0.01% |
+22,065
| New | +$271K |
|
|
VG
857
DELISTED
Vonage Holdings Corporation
VG
| $312K | 0.01% |
27,600
-3,422
| -11% | -$43.5K |
|
858
Lindblad Expeditions
LIND
$2.09B
| $311K | 0.01% |
+18,568
| New | +$338K |
|
859
Primerica
PRI
$9.23B
| $311K | 0.01% |
2,445
-3,549
| -59% | -$428K |
|
860
W.R. Berkley
WRB
$25.9B
| $311K | 0.01% |
9,675
-7,263
| -43% | -$227K |
|
861
BioMarin Pharmaceuticals
BMRN
$12.6B
| $310K | 0.01% |
+4,600
| New | +$354K |
|
862
Emcor
EME
$33.7B
| $310K | 0.01% |
+3,600
| New | +$306K |
|
863
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$379M
| $310K | 0.01% |
+4,284
| New | +$350K |
|
|
FTCH
864
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $310K | 0.01% |
+35,900
| New | +$515K |
|
|
ARD
865
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $309K | 0.01% |
+19,700
| New | +$338K |
|
866
Alamo Group
ALG
$2.01B
| $306K | 0.01% |
+2,600
| New | +$281K |
|
|
PENG
867
Penguin Solutions Inc
PENG
$2.6B
| $306K | 0.01% |
+24,000
| New | +$348K |
|
|
BZUN
868
Baozun
BZUN
$164M
| $304K | 0.01% |
+7,126
| New | +$339K |
|
869
Bausch Health
BHC
$2.5B
| $303K | 0.01% |
13,880
-292,557
| -95% | -$6.69M |
|
|
AGNT
870
AGNT Inc
AGNT
$760M
| $303K | 0.01% |
72,400
+51,200
| +242% | +$243K |
|
871
Stryker
SYK
$126B
| $303K | 0.01% |
+1,400
| New | +$300K |
|
|
WLH
872
DELISTED
WILLIAM LYON HOMES
WLH
| $303K | 0.01% |
14,900
-21,900
| -60% | -$410K |
|
873
Fomento Económico Mexicano
FMX
$41.6B
| $302K | 0.01% |
+3,302
| New | +$305K |
|
874
Franco-Nevada
FNV
$52.1B
| $302K | 0.01% |
3,309
-1,693
| -34% | -$155K |
|
875
iRadimed
IRMD
$1.11B
| $301K | 0.01% |
+14,300
| New | +$292K |
|
Similar funds
Michael Gelband's Q3 2019 Portfolio in Review
As of Q3 2019, Michael Gelband held 1,809 positions worth $2.86B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Michael Gelband deployed $315M of net new capital in Q3 2019, opening 745 new positions and adding to 318 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $41.1M trimmed.
- Michael Gelband's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
- Michael Gelband added most to Aramark in Q3 2019, an estimated $65.8M increase.
- Michael Gelband's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $41.1M.
- Michael Gelband fully exited Altaba Inc in Q3 2019, selling an estimated $68.3M.
- Michael Gelband's ten largest holdings make up 24% of its $2.86B portfolio in Q3 2019.
- Michael Gelband opened 745 new positions and closed 516 in Q3 2019.
- Michael Gelband's portfolio value rose 14% quarter-over-quarter to $2.86B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.